Extended-release Niacin/Laropiprant (MK-0524A)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Extended-release Niacin/Laropiprant (MK-0524A), covering 2013-12-04 to 2013-12-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Extended-release (ER) Niacin/Laropiprant in Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0524A-158) [Phase 1]